Search results for: 'Delivery Technologies for Nutraceuticals'
- Related search terms
- forging AND Casting
- forecasting the global imaging market for 2026
- forecasting the global imaging market for 2024®ions=235
- technologies transforming hvac systems and time global growth opportunities
- technologies transforming hvac systems ad time global growth opportunities
-
11 Jul 2025  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2025
Industry Convergence and Technology Adoption Lead to Transformational Growth
In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...
$4,950.00
Special Price $4,455.00 save 10 %
-
13 Jul 2026  |  Global  |  Technology Research
RNA Therapies in Rare Diseases
Proven clinical success pushing the development of RNA therapies in rare diseases
Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...
$4,950.00 -
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
18 Dec 2025  |  Global  |  Market Research
Growth Opportunities in Cell and Gene Therapeutics Market, Forecast to 2030
Platform Innovation, Regulatory Maturity, and Global Capacity Expansion Are Catalyzing the Next Wave of Growth in Cell and Gene Therapy
The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...
$4,950.00 -
25 Jun 2026  |  Global  |  Technology Research
Quantum Sensors Transitioning from Lab to Industry: Ultra-Precision Measurement for Healthcare, Defense, and Manufacturing
Translating Quantum Innovation into Industry-Ready Measurement Systems
Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environments toward scalable, field-ready systems that meet ...
$4,950.00 -
20 Feb 2025  |  Global  |  Market Outlook
Top 6 Growth Opportunities in Pharma-Biotech, 2025
Unlocking Growth in Precision Therapeutics, Digital Innovation, Manufacturing, and Emerging Markets
The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...
$2,450.00
Special Price $2,205.00 save 10 %
-
23 May 2025  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Real-World Evidence Solutions, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The evolving IT landscape has played a transformative role in the field of life sciences, enabling a reliance on real-world evidence (RWE) solutions. With growing competition and the demand for precision in decision-making, pharmaceutical companies, healthcare providers, and technology organizations have realized the need for real-world data (RWD) ...
$4,950.00
Special Price $4,455.00 save 10 %
-
09 May 2025  |  Global  |  Technology Research
Emerging Anti-aging strategies
Evolving Anti-aging Strategies Are Driving Transformational Growth in Innovation, Market Players, and Emerging Opportunities
This report delves into the rapidly evolving anti-aging industry, highlighting the breakthrough innovations in cellular and genomic rejuvenation as well as AI/ML-driven anti-aging strategies. It explores the industry ecosystem, covering key players, emerging players, and academic researchers transforming the field. The analysis includes major techn...
$4,950.00
Special Price $4,455.00 save 10 %
-
15 May 2025  |  Global  |  Market Research
Immunomodulator Therapeutics Market, Global, 2024–2030
Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies
This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...
$4,950.00
Special Price $4,455.00 save 10 %
-
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00